Pipeline
Topas is utilizing its cutting-edge nanoparticle technology platform to develop a pipeline of novel therapies to treat autoimmune and antigen-driven diseases.
- Preclinical
- Phase 1
- Phase 2
- Phase 3
- Celiac disease TPM502
- Pemphigus vulgaris TPM203
- Multiple sclerosis
- Other indications